- IBA debuts compact synthesizer for radiopharmaceutical manufacturing
May 14, 2025
- Ratio Therapeutics plans radiopharmaceutical manufacturing site in Salt Lake City
May 12, 2025
- SHINE Technologies to acquire Lantheus’ SPECT division
May 07, 2025
- GE HealthCare announces FDA clearance for Aurora, dual-head SPECT/CT, and Clarify DL, AI-powered image reconstruction tech
May 06, 2025
- Blue Earth Therapeutics begins phase 2 trial of lutetium-based radioligand for prostate cancer
May 06, 2025
- SpectronRx passes FDA inspection with no observations for Indianapolis facility
April 30, 2025
- SHINE enters UAE market with Modawina partnership for Lu-177 distribution
April 24, 2025
- PET procedure volumes in US rose 12% in 2024
April 23, 2025
- SHINE and Sumitomo form partnership to expand radioisotope supply in Asia
April 08, 2025
- FDA clears Novartis’ Pluvicto for earlier use in PSMA-positive prostate cancer
April 02, 2025
- GE HealthCare takes full ownership of Nihon Medi-Physics in Japan
April 01, 2025
Older Stories